Ultra-low Doses of Follicle Stimulating Hormone and Progesterone Attenuate the Severity of Polycystic Ovary Syndrome Features in a Hyperandrogenized Mouse Model

BACKGROUND: Polycystic-ovary syndrome (PCOS) is a reproductive illness characterized by hyperandrogenism and anovulation. Using hyperandrogenized mice, it was demonstrated that the oral administration of incremental dose of follicle stimulating hormone (FSH) attenuated some of PCOS characteristics....

Descripción completa

Detalles Bibliográficos
Autores principales: Tessaro, Irene, Modina, Silvia, Lodde, Valentina, Sivelli, Giulia, Franciosi, Federica, Terzaghi, Laura, Luchini, Patrizia, Rumio, Cristiano, Luciano, Alberto Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Research Institute 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641438/
https://www.ncbi.nlm.nih.gov/pubmed/29062793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641438/
https://www.ncbi.nlm.nih.gov/pubmed/29062793

Ejemplares similares